Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
6.12
-0.05 (-0.81%)
Nov 21, 2024, 10:43 AM EST - Market open
Adverum Biotechnologies Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -94.11 | -117.17 | -154.54 | -145.54 | -117.51 | -64.49 | |
| Depreciation & Amortization | 3.85 | 5.64 | 6.53 | 4.65 | 4.16 | 1.57 | |
| Loss (Gain) From Sale of Assets | -0.03 | 0.05 | 0.12 | - | - | - | |
| Asset Writedown & Restructuring Costs | 0.22 | 0.22 | 2.12 | 1.06 | - | - | |
| Loss (Gain) From Sale of Investments | -1.39 | -1.94 | -0.88 | 2.77 | 0.52 | -1.27 | |
| Stock-Based Compensation | 15.22 | 17.57 | 20.08 | 25.19 | 20.39 | 9.9 | |
| Other Operating Activities | 2.4 | 13.03 | 2.62 | -0.03 | 0.42 | 0.06 | |
| Change in Accounts Payable | -0.12 | -0.37 | 0.85 | -1.61 | 1.59 | -0.65 | |
| Change in Other Net Operating Assets | -11.58 | -7.95 | 15 | 5.67 | 11.14 | 5.71 | |
| Operating Cash Flow | -85.54 | -90.9 | -108.09 | -107.83 | -79.29 | -49.17 | |
| Capital Expenditures | -0.52 | -0.81 | -11.82 | -15.12 | -11.84 | -19.25 | |
| Investment in Securities | -47.06 | 97.68 | 153.54 | 93.83 | -268.32 | -48.83 | |
| Investing Cash Flow | -47.58 | 96.88 | 141.72 | 78.71 | -280.17 | -68.07 | |
| Long-Term Debt Repaid | - | - | - | -0.24 | -0.06 | -0.11 | |
| Net Debt Issued (Repaid) | - | - | - | -0.24 | -0.06 | -0.11 | |
| Issuance of Common Stock | 120.01 | 0.49 | 0.61 | 2.64 | 358.09 | 29.77 | |
| Repurchase of Common Stock | - | - | - | - | -2.04 | -1.47 | |
| Other Financing Activities | -0.08 | -0.42 | - | - | - | - | |
| Financing Cash Flow | 119.93 | 0.07 | 0.61 | 2.4 | 355.99 | 28.19 | |
| Net Cash Flow | -13.19 | 6.04 | 34.24 | -26.73 | -3.47 | -89.05 | |
| Free Cash Flow | -86.06 | -91.71 | -119.91 | -122.95 | -91.14 | -68.42 | |
| Free Cash Flow Margin | -8606.00% | -2547.50% | - | -1639.39% | - | -27366.80% | |
| Free Cash Flow Per Share | -5.04 | -9.10 | -12.08 | -12.54 | -10.70 | -10.67 | |
| Levered Free Cash Flow | -47.6 | -60.69 | -72.63 | -80.16 | -54.76 | -52.12 | |
| Unlevered Free Cash Flow | -47.6 | -60.69 | -72.63 | -80.16 | -54.76 | -52.12 | |
| Change in Net Working Capital | 1.86 | 5.74 | -6.52 | 4.21 | -6.25 | 1.51 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.